Studying immune markers in people with osteoporosis
Part of Bones, joints & muscles clinical trials.
This study looks at immune system “fingerprints” (immunophenotyping) in adults who have been diagnosed with osteoporosis. It may help researchers understand what drives osteoporosis and could guide better future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a confirmed diagnosis of osteoporosis.
- You can sign written consent to take part in the study.
- You do not have a diagnosis of “secondary osteoporosis” (osteoporosis caused by another condition).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how blood-forming stem cells change in people with clonal hematopoiesis (CHIP), a common age-related blood condition. It may help researchers understand what these changes mean and who might be at higher risk for future blood problems.
This study looks for new markers and treatment targets for osteoporosis by comparing bone tissue from women with a broken hip (due to weak bones) and women getting a hip replacement for arthritis. You may be eligible if you are postmenopausal and have one of these hip conditions.
This study collects information and samples around the time of certain bone or joint surgeries (like joint replacement or fracture repair) to learn what factors help or harm bone healing. The results may help find better targets to improve long-term bone health and recovery.
This study looks at how certain immune cells (natural killer T cells) behave in people with systemic lupus, by measuring specific immune receptor markers in blood. It may help researchers better understand lupus and how it can connect with other conditions like antiphospholipid syndrome or Sjögren’s.
This study asks people with osteoporosis about what it’s like to join and go through clinical trials. Your feedback may help improve how future osteoporosis studies are done and supported.
This study tests two injectable medications (romosozumab and abaloparatide) that help strengthen bones in women after menopause. Researchers will also look at blood markers to understand why some women respond better to treatment than others.
Hear when a new Immunophenotyping Blood Samples of Patients With Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.